Especially, tryptophan and glycerophospholipid metabolism, and related targets such as TGM2, BCHE and PLA2G2A should be paid more attention, since the regulation of leonurine on these two pathways was also observed in our previous metabolomics study of clinical hyperlipidemia patients. The gene discussed is PLA2G2A; the disease is hyperlipidemia.